[Effects of beta-blockers on intermediary metabolism].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000818:Animals; D050260:Carbohydrate Metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D009132:Muscles / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D007328:Insulin
Effets des bêta-bloqueurs sur le métabolisme intermédiaire